12.2.05
New Oracle Partnership Drives Continued Development of EKM Corp.'s Knowledge Management Products
New Oracle Partnership Drives Continued Development of EKM Corp.'s Knowledge Management Products: "-A new partnership with Oracle will allow San Diego-based EKM Corp. to further penetrate the scientific and government marketplaces with its popular knowledge management software.
In the government sector, the partnership will allow EKM to enhance the company's AFIS financial reporting applications with more extensive integration of the Oracle product line. EKM has already successfully supplied its financial management technology to the U.S. Navy and U.S. Army.
In the scientific sector, EKM, now a member of the Oracle Partner Network, will have access to new Oracle technologies created specifically for the life science market. One of those technologies is BLAST, an algorithm used for looking for patterns in genes and technologies that Oracle is importing into its life science offerings. These types of new technologies can now be integrated with EKM's electronic lab notebook software LABTrack.
LABTrack, which already uses Oracle data management software, runs on any Windows-based device. It is the first electronic lab notebook that allows researchers to format electronic pages that mirror paper-based notebooks, but offers powerful database and searching functionality.
'This partnership benefits our customers because EKM can take advantage of the newest technologies that Oracle offers in advance of product releases, and incorporate them into LABTrack,' said Richard Stember, CEO of EKM's Scientific Division. 'We are very excited about the future possibilities this offers in the continuing development of electronic lab notebooks.'
According to IDC Research, Oracle has 63.4 percent, or $356 million, of the global life science market for commercial databases. The strategic partnership will not only allow EKM to access Oracle's dominant life science market share, but it will also benefit current and future life science users of LABTrack.
'It will allow life science customers to leverage their competencies and investment in Oracle's databases and architecture, relational database management systems and data mining enhancements,' said Thomas Chung, chair of EKM's Scientific Advisory Board. 'The power of these best-in-class data analysis tools will allow research-based organizations to make informed research and business decisions. This will improve research productivity, accelerate product discovery and development, and speed up time-to-market for LABTrack users.'" ¶ 10:04
In the government sector, the partnership will allow EKM to enhance the company's AFIS financial reporting applications with more extensive integration of the Oracle product line. EKM has already successfully supplied its financial management technology to the U.S. Navy and U.S. Army.
In the scientific sector, EKM, now a member of the Oracle Partner Network, will have access to new Oracle technologies created specifically for the life science market. One of those technologies is BLAST, an algorithm used for looking for patterns in genes and technologies that Oracle is importing into its life science offerings. These types of new technologies can now be integrated with EKM's electronic lab notebook software LABTrack.
LABTrack, which already uses Oracle data management software, runs on any Windows-based device. It is the first electronic lab notebook that allows researchers to format electronic pages that mirror paper-based notebooks, but offers powerful database and searching functionality.
'This partnership benefits our customers because EKM can take advantage of the newest technologies that Oracle offers in advance of product releases, and incorporate them into LABTrack,' said Richard Stember, CEO of EKM's Scientific Division. 'We are very excited about the future possibilities this offers in the continuing development of electronic lab notebooks.'
According to IDC Research, Oracle has 63.4 percent, or $356 million, of the global life science market for commercial databases. The strategic partnership will not only allow EKM to access Oracle's dominant life science market share, but it will also benefit current and future life science users of LABTrack.
'It will allow life science customers to leverage their competencies and investment in Oracle's databases and architecture, relational database management systems and data mining enhancements,' said Thomas Chung, chair of EKM's Scientific Advisory Board. 'The power of these best-in-class data analysis tools will allow research-based organizations to make informed research and business decisions. This will improve research productivity, accelerate product discovery and development, and speed up time-to-market for LABTrack users.'" ¶ 10:04
